End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Matthew Pauls
CEO | Chief Executive Officer | 53 | 17-04-26 |
David Lowrance
DFI | Director of Finance/CFO | 56 | 17-04-26 |
Robert M. Lutz
COO | Chief Operating Officer | 55 | 23-02-12 |
Raymond Pratt
CTO | Chief Tech/Sci/R&D Officer | 73 | 22-11-09 |
Anne Erickson
IRC | Investor Relations Contact | - | 18-09-30 |
Charles LaPree
LAW | General Counsel | - | 21-07-31 |
Kate McCabe
LAW | General Counsel | - | 18-02-28 |
Scott Wilhoit
PRN | Corporate Officer/Principal | 61 | 23-01-08 |
Peter M. Clarke
PRN | Corporate Officer/Principal | 64 | 21-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Ramsay
BRD | Director/Board Member | 59 | 17-04-26 |
Richard Hawkins
BRD | Director/Board Member | 75 | 10-09-30 |
Nevan Elam
BRD | Director/Board Member | 56 | 09-01-31 |
Ricky Sun
BRD | Director/Board Member | 50 | 19-12-23 |
Joseph McCracken
BRD | Director/Board Member | 70 | 17-04-26 |
Matthew Pauls
CEO | Chief Executive Officer | 53 | 17-04-26 |
Director/Board Member | 64 | 19-12-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 138,148,141 | 129,628,695 ( 93.83 %) | 0 | 93.83 % |
Company contact information
Savara, Inc.
1717 Langhorne Newtown Road Suite 302
19047, Langhorne
+(512) 614-1848
http://www.savarapharma.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- SVRA Stock
- Stock
- Company Savara Inc